Literature DB >> 3949951

Calcitonin deficiency in primary hypothyroidism.

J J Body, N Demeester-Mirkine, A Borkowski, S Suciu, J Corvilain.   

Abstract

The relative lack of sensitivity and specificity of current assays for plasma calcitonin (CT) have made it difficult to study possible CT deficiency conditions. Using a new extraction method that considerably improves the sensitivity of the assay for CT monomer, CT levels were measured before and after a short calcium (Ca) stimulation test (2 mg Ca/kg over 5 min) to determine C-cell secretory reserve in women with autoimmune primary hypothyroidism and normal women. Mean basal plasma CT concentrations were lower in the hypothyroid women [0.9 +/- 0.1 (+/- SEM) pg/ml] than in the normal women (1.5 +/- 0.2 pg/ml; P less than 0.01). Serum Ca increased similarly in both groups, but postinfusion CT levels were lower in the women with primary hypothyroidism (3.8 +/- 1.3 pg/ml) than in normal women (15.9 +/- 3.0 pg/ml; P less than 0.001). The functional thyroid status at the time of the study did not influence CT levels; both hypothyroid patients (n = 10) and patients who were euthyroid during T4 treatment (n = 11) were CT deficient to the same extent. Unlike that in primary hypothyroidism, CT secretion was normal in four patients with hypothyroidism of pituitary origin. We conclude that the process that causes hypothyroidism in patients with autoimmune thyroid disease can also cause marked CT deficiency. This first demonstration of spontaneous CT deficiency in adults should contribute to the understanding of CT physiology; it also suggests that bone metabolism should be closely monitored during the treatment of primary hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949951     DOI: 10.1210/jcem-62-4-700

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Nasal human calcitonin for tumor-induced hypercalcemia.

Authors:  J C Dumon; A Magritte; J J Body
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

2.  Calcitonin and bone mass status in congenital hypothyroidism.

Authors:  N Demeester-Mirkine; P Bergmann; J J Body; J Corvilain
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

3.  Contribution of thyroid ultrasound and serum calcitonin to the diagnosis of congenital hypothyroidism.

Authors:  J P Chanoine; V Toppet; J J Body; G Van Vliet; R Lagasse; P Bourdoux; M Spehl; F Delange
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

4.  Presence or severity of Hashimoto's thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank.

Authors:  M Cvek; A Punda; M Brekalo; M Plosnić; A Barić; D Kaličanin; L Brčić; M Vuletić; I Gunjača; V Torlak Lovrić; V Škrabić; V Boraska Perica
Journal:  J Endocrinol Invest       Date:  2021-10-06       Impact factor: 4.256

5.  Growth prognosis and growth after menarche in primary hypothyroidism.

Authors:  S Pantsiouou; R Stanhope; M Uruena; M A Preece; D B Grant
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

6.  Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation.

Authors:  Richard Lantz; Brian Busbee; Ewa P Wojcikiewicz; Deguo Du
Journal:  Biopolymers       Date:  2019-12-05       Impact factor: 2.240

7.  High rates of (treated) hypothyroidism among chronic migraine patients consulting a specialized headache clinic: are we missing something?

Authors:  Marcelo Filipchuk; Jesica Gassmann; Tatiana Castro Zamparella; Maria Cecilia Tibaldo; Mariela Carpinella; Pablo Sesto Tagliavini; Pablo Scarnato; Maria Teresa Goicochea; Osvaldo Bruera; Diego Martin Conci Magris; Marco Lisicki
Journal:  Neurol Sci       Date:  2021-07-20       Impact factor: 3.830

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.